Dr. Anna D. Barker

Arizona State University

Why We Have So Few Cancer Biomarkers

Biomarkers provide the highest value proposition for cancer, says Dr. Anna Barker, Professor, Arizona State University. Although published data show the discovery of hundreds of thousands of biomarkers in cancer, only about 100 are approved and only around 10 actually used in the clinic. Why is there such a mismatch in numbers between discovery and application, then? Barker goes on to explain what truly makes a clinically relevant biomarker.

LIKE 0


Dr. Anna D. Barker
Precision Medicine

Dr. Anna D. Barker

Biography

Dr. Barker directs efforts... More

Dr. Anna D. Barker

Arizona State University

Dr. Barker directs efforts in transformative knowledge networks at ASU – specifically directed toward the development of new research models that leverage convergent knowledge, innovative teams and novel funding approaches to better prevent and treat acute and chronic diseases. She also serves as Co-Director of Complex Adaptive Systems at ASU which serves as an organizing construct to understand and solve multi-dimensional problems in the biological and social and sciences.